“…Additionally, pharmaceutical bioavailability and nutrient digestibility in pigs closely resemble that of humans (19, 25, 43). These characteristics have led to the use of pigs for the development of pig models of a number of gastrointestinal diseases including necrotizing enterocolitis (16, 44–48), acute mesenteric ischemia (18, 49–52), short bowel syndrome (43, 53–57), AIDS-associated Cryptosporidium infection (17, 58, 59), stress-induced intestinal dysfunction (60–63), cystic fibrosis (64, 65) and familial adenomatous polyposis (14). This review will highlight strengths and limitations of pig models of intestinal ischemia/reperfusion injury, stress-induced intestinal dysfunction and short bowel syndrome.…”